US FTC to sue drug middlemen over insulin prices, source says

​On Tuesday, the FTC issued an interim report, saying the three biggest middlemen – managing 79% of U.S. prescription drug claims – have used years of dealmaking to gain outsized influence on drug prices. The report said the companies enriched themselves at the expense of smaller pharmacies and consumers.